Dr. Kasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Fivepoint
Irvine, CA 92618Phone+1 800-826-4673
Summary
- Associate Professor Oncology,
Post-Doctoral Master’s in Basic and Biomedical Sciences.
Clinical Expertise
- Immunotherapy, Biological Therapy, Medical oncology, Hematology, Toll-Like Receptor 4, Tumor Cell Line, Combined modality therapy, Adjuvant chemotherapy, Gastrointestinal / Hepatic pathology, Colonic neoplasms, Cholangiocarcinoma, Pancreatic Neoplasms, BRCA2 Genes, BRCA1 Genes, Gastrointestinal oncology, Hematologic oncology, Colon cancer, Liver metastases, Metastatic diseases, Hepatic metastases, Metastatic colon cancer, Colorectal cancer, Hereditary nonpolyposis colorectal cancer, General medical oncology, Pancreatic cancer, Hepatic cancer
Education & Training
Mayo School of Graduate Medical EducationM.S., Basic and Biomedical Sciences , 2015 - 2018
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2013 - 2016
UPMC Medical EducationResidency, Internal Medicine, 2010 - 2013
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Transitional Year, 2009 - 2010
Aga Khan Medical CollegeClass of 2006
Certifications & Licensure
CA State Medical License 2024 - 2026
FL State Medical License 2016 - 2026
IA State Medical License 2019 - 2025
MN State Medical License 2013 - 2025
NY State Medical License 2021 - 2025
PA State Medical License 2010 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Teamwork - Above and Beyond Recognition Program Mayo Clinic, 2017
- Excellence - Above and Beyond Recognition Program Mayo Clinic, 2017
- Tow Tan Humanism in Medicine Mayo Clinic, 2016
- Join now to see all
Clinical Trials
- R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2016 May 20
- EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
- FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2016 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsTucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-la...John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng
The Lancet. Oncology. 2023-05-01 - 11 citationsNeoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, Heather Yeo, Lea Lowenfeld
Oncogene. 2023-10-01 - 46 citationsThe Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.Alexandra W. Elias, Pashtoon Murtaza Kasi, John A. Stauffer, David D. Thiel, Dorin T. Colibaseanu
Frontiers in Oncology. 2017-06-12
Journal Articles
- Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic CancerPashtoon M Kasi, Robert R McWilliams, JAMA
Lectures
- A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Circulating tumor DNA dynamics, serial testing and evolution on treatment in 322 colorectal cancer patients.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Join now to see all
Press Mentions
Active Surveillance or Maintenance After Chemo Induction in Metastatic CRC?March 8th, 2022- Detecting Cancer with a Simple Blood Draw Could Soon Be a RealityNovember 24th, 2021
- Is the Pandemic-Era Telehealth Boom Coming to an End?September 8th, 2021
- Join now to see all
Grant Support
- Colon Cancer - Career Development AwardNorma Lee and Morton Funger Clinician Career 2017 Development Fund Award in Colon Cancer Research ($150,000) for establishment and molecular characterization of a patient-derived colorectal cancer tissue2017–2020
- BRCA-Related Pancreatic Cancer: Outcomes and PD-L1 expressionMayo Clinic Cancer Center2017–2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
